Advanced Technology Offering Gives Fabless Customers a Faster and Lower-Cost Route to Market

The MOSIS Service, a leading provider of semiconductor fabrication solutions, today announced that it has expanded its relationship with IBM to now include silicon-on-insulator (SOI) technology at multiple advanced lithography nodes. MOSIS is offering IBM's 45-nm SOI technology on 300mm wafers and IBM's 180-nm SOI technology on 200mm wafers. MOSIS customers now have a low-cost route to prototyping and low-volume production with leading-edge SOI foundry technologies that provide enhanced performance and very high integration capabilities.

The initial 45-nm shuttle run is scheduled for September 1, 2009. IBM's 45-nm 12S0 technology is the company's sixth generation of leading-edge SOI technologies and the first 300mm SOI technology to be offered through the MOSIS Service. This process provides significant transistor performance improvement (up to 30 percent) over traditional bulk technology at the same lithography node. The 45-nm SOI process offers four transistor options (Regular, High Vt, Super High Vt, Ultra High Vt), in addition to up to 11 metallization layers. A range of SRAM (Static Random Access Memory) and embedded DRAM (Dynamic Random Access Memory) options are also available, as well as a number of ESD (Electrostatic Discharge) protection options and high-quality passive elements. In addition to providing excellent isolation for analog circuit performance, this SOI offering can reduce the circuit area by up to 25 percent relative to bulk CMOS, which cuts the cost of overall semiconductor content.

The first available 180-nm SOI shuttle run has successfully been completed, with the next shuttle run scheduled for September 14, 2009. The low insertion loss and high isolation makes this technology an ideal choice for components such as RF switches that perform the function of On/Off devices in wireless applications like cell phones, WiMAX and WLANs (Wireless Local Area Networks). "MOSIS is delighted to partner with IBM to now offer SOI foundry technologies," said Wes Hansford, Deputy Director of MOSIS. "The 180-nm 7RF SOI technology provides a very compelling alternative to GaAS (Gallium Arsenide) technology for RF switches, while the 45-nm SOI technology delivers outstanding performance while maximizing power efficiency and minimizing overall chip size for SOC (System-on-Chip) applications. By broadening our portfolio, MOSIS provides a single interface between designers and a greater range of foundry services, thereby enabling our clients with a faster and lower-cost route to market."

"This is a natural next step for our partnership with MOSIS and makes our advanced SOI technology accessible to an even broader array of innovators," said Regina Darmoni, IBM's Director of Analog/Mixed Signal & Digital Foundry. "MOSIS provides IBM with additional channels to market, and we are looking forward to this further expansion of our fabrication solutions to enable a new generation of advanced devices and clients."

Since 1981, MOSIS has fabricated more than 50,000 circuit designs for commercial firms, government agencies, and research and educational institutions around the world. MOSIS has been a partner of IBM since 2001 and today provides MPW (multi project wafer) services to enable lowcost prototyping, dedicated engineering runs, and low- to- medium-volume production through IBM's semiconductor fabs. MOSIS has now become a significant player in the semiconductor foundry industry by providing complete foundry solutions (including IC packaging and test) that are cost effective and have strong technical support. MOSIS provides designers with a single interface to a large portfolio of semiconductor technologies and greatly simplifies the task of working with many of the leading semiconductor foundries.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.